Datametrex AI (DM) AI Stock Analysis

• Market Cap: C$3.89M
• Dividend Yield: N/A
• Average Volume (3M): 89.95K
• Price to Earnings (P/E): ―
• Beta (1Y): 3.18
• Revenue Growth: -56.02%
• EPS Growth: 91.71%
• Country: CA
• Employees: 21
• Sector: Technology
• Sector Strength: 88
• Industry: Information Technology Services
• EPS (TTM): -0.02
• Shares Outstanding: 32,386,005
• 10 Day Avg. Volume: 133,964
• 30 Day Avg. Volume: 89,955
• PEG Ratio: 0.01
• Price to Book (P/B): 4.39
• Price to Sales (P/S): 0.44
• P/FCF Ratio: -1.84
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: C$0.10 ▼(-2.00% Downside)

The overall stock score is primarily impacted by significant financial challenges, including declining revenues and negative profitability. While technical indicators provide some neutral signals, the negative valuation metrics further weigh down the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

AI and Data Analytics Focus

The company's focus on AI and data analytics positions it well in a growing industry, leveraging advanced technologies to enhance decision-making and operational efficiency.

Diverse Revenue Streams

Diverse revenue streams from subscriptions, licensing, and consulting provide stability and flexibility, allowing the company to adapt to market demands and enhance earnings potential.

Strategic Partnerships

Strategic partnerships enhance service offerings and market reach, fostering growth opportunities and competitive advantages in the technology sector.

Negative Factors

Declining Revenue

Significant revenue decline indicates challenges in market demand or competitive positioning, impacting long-term financial stability and growth prospects.

High Leverage

High leverage suggests heavy reliance on debt financing, which can strain financial flexibility and increase risk during economic downturns.

Weak Cash Flow

Weak cash flow performance limits the company's ability to invest in growth opportunities and manage financial obligations, posing a risk to long-term sustainability.

Datametrex AI Business Overview & Revenue Model

Company Description

Datametrex AI Limited, together with its subsidiaries, provides collecting, analyzing, and presenting structured and unstructured data using its patented machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Security. It offers health security services, such as COVID-19 related services, concierge medical services, and telemedicine services, as well as big data, artificial intelligence, and system integration services. The company also sells Covid-19 test kits. In addition, it provides NexaSecurity, a social-media discovery and monitoring platform; Nexalogy's Social Media Automated Reporting Technologies; and Datametrex EV solutions. Further, the company provides Medi-Call health app, a subscription service that connects patients with doctors, providing technology-driven e-health or m-health care services including prescriptions and in-person visits to a residential or work setting. Datametrex AI Limited is headquartered in Toronto, Canada.

How the Company Makes Money

Datametrex AI generates revenue through a combination of software licensing, subscription services, and consulting fees. The company offers its AI and data analytics solutions on a subscription basis, allowing clients to access its platforms and tools for a recurring fee. Key revenue streams also include one-time licenses for software products, custom consulting services tailored to specific client needs, and partnerships with other technology firms that enhance service offerings. Additionally, Datametrex AI engages in strategic collaborations that expand its market reach and capabilities, contributing to its overall earnings.

Datametrex AI Financial Statement Overview

Summary

Datametrex AI is facing significant financial challenges, with declining revenues, negative profitability, high leverage, and weak cash flow generation. The company needs to address these issues to improve financial stability and performance.

Income Statement

The company has experienced a significant decline in revenue over the past year, with a revenue growth rate of -43.31%. Profitability metrics are weak, with negative net profit and EBIT margins indicating ongoing losses. The gross profit margin is moderate at 47.35%, but overall financial performance is concerning due to persistent negative earnings.

Balance Sheet

The balance sheet shows high leverage with a debt-to-equity ratio of 2.80, indicating significant reliance on debt financing. Return on equity is negative, reflecting losses and poor shareholder returns. The equity ratio is low, suggesting limited financial stability. These factors highlight potential financial risks.

Cash Flow

Cash flow metrics are weak, with negative operating and free cash flows. The free cash flow growth rate is -27.04%, indicating deteriorating cash generation. The operating cash flow to net income ratio is negative, reflecting cash flow challenges. Overall, cash flow performance is concerning.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.11M	6.49M	7.80M	30.49M	49.03M	12.38M
Gross Profit	2.42M	3.07M	2.17M	10.20M	21.03M	2.99M
EBITDA	-928.15K	-1.24M	-6.95M	-13.46M	13.29M	-3.60M
Net Income	-2.66M	-3.06M	-19.14M	-17.26M	9.09M	-5.01M
Balance Sheet
Total Assets	5.96M	4.99M	12.71M	36.00M	42.64M	10.00M
Cash, Cash Equivalents and Short-Term Investments	253.76K	427.11K	1.13M	9.41M	17.99M	1.97M
Total Debt	2.14M	1.84M	5.19M	4.53M	253.77K	518.58K
Total Liabilities	4.87M	4.33M	11.70M	13.23M	10.15M	6.75M
Stockholders Equity	1.09M	656.40K	1.00M	22.77M	32.49M	3.25M
Cash Flow
Free Cash Flow	-2.01M	-1.57M	-6.94M	-2.28M	11.42M	-611.50K
Operating Cash Flow	-1.70M	-1.22M	-5.62M	-249.09K	11.45M	-595.10K
Investing Cash Flow	-273.93K	59.10K	-969.15K	-3.79M	-234.41K	-14.93K
Financing Cash Flow	1.84M	1.21M	-254.18K	-2.40M	2.19M	2.48M

Datametrex AI Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.10
• 50DMA: Negative
• 100DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DM, the sentiment is Negative. The current price of 0.1 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.78 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:DM.

Datametrex AI Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
DM	46 Neutral	C$3.89M	―	-58.58%	―	-56.02%	91.71%
VIS	41 Neutral	C$3.87M	-3.26	-3428.85%	―	-15.33%	47.13%
NERD	41 Neutral	$2.24M	―	―	―	13.01%	20.00%
PAID	41 Neutral	C$7.08M	-0.34	―	―	30.97%	18.42%
FARM	40 Underperform	C$8.31M	-0.12	―	―	-18.97%	-55.19%
DCSI	37 Underperform	$4.97M	-3.03	―	―	25.65%	-383.49%

Datametrex AI Corporate Events

Datametrex’s Imagine Health Opens New Edmonton South Clinic

Datametrex AI Limited’s subsidiary, Imagine Health Medical Clinics Ltd., has relocated its Edmonton South clinic to a modern facility, enhancing its ability to provide high-quality, patient-focused care. This move aligns with Imagine Health’s mission to meet the evolving healthcare needs of the community, offering a comprehensive range of services including family medicine and specialized medical care.

Datametrex Expands Healthcare Reach with New Calgary Clinic

Datametrex AI Limited announced the relocation of its subsidiary, Imagine Health Medical Clinics, to a new location in Calgary’s Capitol Hill area. This move aims to enhance patient care and accessibility, reflecting the company’s commitment to providing high-quality healthcare services. The new facility is fully operational and accepting new patients, indicating a strategic expansion in the Calgary community.

Datametrex Expands Healthcare Services with New Calgary Clinic

Datametrex AI Limited has announced the relocation of its subsidiary, Imagine Health Medical Clinics, to a new facility in Calgary’s Capitol Hill. This move aims to enhance patient care and accessibility, reflecting the company’s commitment to providing high-quality healthcare services. The new clinic is fully operational and accepting new patients, further solidifying Imagine Health’s presence in Calgary and its dedication to meeting the community’s healthcare needs.

Datametrex AI Secures $5.1 Million Through Financing Closures

Datametrex AI Limited has successfully closed its non-brokered private placement and subscription receipt financing, raising a total of $5,133,500. The funds will be used to integrate the Yuzu Payment Solution into its technology division and support business expansion, including the establishment of a new clinic. The completion of the subscription receipt financing is crucial for the acquisition of Yuzu Payment Solution, with specific conditions set for the release of funds from escrow.

Datametrex AI Sets Closing Date for $5.3 Million Financing

Datametrex AI Limited has announced the closing date for its non-brokered private placement and subscription receipt financing, set for November 14, 2025. The company aims to raise up to $5.3 million to support business expansion, the integration of Yuzu Payment Solution, and general working capital, potentially impacting its market positioning and operational capabilities.

Datametrex AI Appoints New Board Member to Strengthen Governance

Datametrex AI Limited has appointed Mr. Enrico Moretti, a securities lawyer with extensive cross-border legal expertise, to its Board of Directors to fulfill the minimum director requirement under Exchange policies. This appointment aims to strengthen the company’s governance and compliance framework, as the company works diligently to address a trading halt imposed by the Exchange due to the previous deficiency in board composition. Mr. Moretti’s expertise is expected to be a valuable asset in enhancing the company’s corporate governance and regulatory compliance.

Datametrex AI Upsizes Private Placement to Bolster Payment Solutions

Datametrex AI Limited has announced plans to upsize its non-brokered private placement financings, seeking approval from the TSX Venture Exchange to increase the private placement of common shares from $3 million to $4 million and the financing of subscription receipts from $1 million to $1.3 million. The proceeds will be used to integrate the Yuzu Payment Solution into Datametrex’s technology division, pursue merchant opportunities, and for general working capital. This strategic move aims to strengthen Datametrex’s position in the tech industry by enhancing its payment solutions and expanding its market reach.

Datametrex AI Announces Financing for Yuzu Payment Integration

Datametrex AI Limited has announced the terms of its private placement financings, which include a non-brokered private placement of up to $3,000,000 of common shares and a non-brokered private placement of up to $1,000,000 of subscription receipts. The proceeds from these financings will be used to integrate the Yuzu Payment Solution into Datametrex’s technology division, aiming to generate revenue through merchant opportunities. This strategic move is expected to enhance Datametrex’s operations and strengthen its position in the fintech industry.

Datametrex AI to Acquire Yuzu Payment Solution to Boost Growth in Payments Sector

Datametrex AI Limited has signed a non-binding Letter of Intent to acquire the Yuzu payment processing solution from Firstpayment Inc., a Montreal-based fintech company. This acquisition, valued at approximately $5.5 million, will be paid through the issuance of common shares and aims to commercialize Yuzu’s cryptocurrency payment solutions. The acquisition is expected to accelerate Datametrex’s growth in the payments sector and leverage existing relationships with various merchant categories, potentially generating new revenue streams. The transaction is subject to customary closing conditions and regulatory approvals.